Insider trade

Director sold ~$61K of ELV shares in the open market

Traded Jun 11, 2026 · Filed Jun 12, 2026

Elevance HealthELV

~$61K
Reported value · 151 sh @ $401.77: 11K
Holds after · shares reported: -4.4%
stock since the trade · S&P 500 +3.6%, $399.18 → $381.67 on Oct 1

Why it stands out

A board member of Elevance Health sold $61K of Elevance Health shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jun 11, 2026
Reporting period: Not applicable
Filed with the SEC: Jun 12, 2026

Director$25K–$100K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$60,667

Shares × reported transaction price

Timing vs results

50 days after results of Apr 22, 2026, 34 days before results of Jul 15, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $399.18 on Jun 11, 2026, 45% above its 52-week low and 6% below its high, after a 6% rise over the previous 30 trading days

52-week range $274.66 (Aug 1, 2025) to $424.43 (Jun 9, 2026), 83% of the way up, from 251 adjusted closes. 30 trading days earlier: $376.63 on Apr 29, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on May 12, 2025 in the U.S. District Court, S.D. Indiana. A filing is an allegation, not a finding.

MILLER v. ELEVANCE HEALTH, INC., docket 1:25-cv-00923, via CourtListener (court records). Nature of suit 850, company named as first defendant